# REGENERATE (genetic and multi-cancer test education for people at pancreatic cancer risk)

Source: https://onco.cc/trials/regenerate-pancreatic-genetics-mced/  
OnCo record `regenerate-pancreatic-genetics-mced` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A small randomised study of how to help people at higher risk of pancreatic cancer decide about genetic testing and a multi-cancer blood test.

## Summary

REGENERATE (NCT07787156) is a randomised interventional study sponsored by Brigham and Women's Hospital with Pancreatic Cancer Action Network, Exact Science Corporation, Dana-Farber Cancer Institute and others. Its primary outcomes are the feasibility of completing genetic and multi-cancer testing, acceptability and fidelity; Exact Sciences and the Pancreatic Cancer Action Network are collaborators.

The registry record, read on 29 October 2026, gives its status as recruiting, with an estimated 80 participants, a start on 15 October 2026 and primary completion expected in September 2028.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-29
- Also known as: REGENERATE
- Registry id: NCT07787156
- Phase: not-applicable
- Setting: Black, Latino/a and Medicaid-enrolled people in Massachusetts who may be at higher risk of pancreatic cancer, randomised to online education alone or with a phone session before choosing genetic testing and multi-cancer testing
- Sponsor: Brigham and Women's Hospital with Pancreatic Cancer Action Network, Exact Science Corporation, Dana-Farber Cancer Institute, Winn Career Development Award
- Enrolled: 80

## Sources

- ClinicalTrials.gov NCT07787156: https://clinicaltrials.gov/study/NCT07787156

## Connected records

- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Germline (hereditary) testing](https://onco.cc/technologies/germline-testing/), [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- companies: [Exact Sciences (Abbott)](https://onco.cc/companies/exact-sciences/)

---
JSON: https://onco.cc/api/v1/entities/regenerate-pancreatic-genetics-mced.json